Download PDF

Other users also viewed these articles

The safety and efficacy of tolvaptan in the treatment of patients with autosomal dominant polycystic kidney disease: A systematic review and meta-analysis Xuanwei Li; Wenlai Li; Yue Li; Chuanjiang Dong; Ping Zhu;
Nefrologia (English Version). 2023;43:731-41
Consensus document on autosomal dominant polycystic kindey disease from the Spanish Working Group on Inherited Kindey Diseases. Review 2020 Elisabet Ars; Carmen Bernis; Gloria Fraga; Mónica Furlano; Víctor Martínez; Judith Martins; Alberto Ortiz; Maria Vanessa Pérez-Gómez; José Carlos Rodríguez-Pérez; Laia Sans; Roser Torra;
Nefrologia (English Version). 2022;42:367-89
[Genetic study in young patients with chronic kidney disease stage G5 from unknown etiology. The GENSEN study design Miquel Blasco; Borja Quiroga; José M. García-Aznar; Roser Torra; Alberto Ortiz; Patricia de Sequera;
Nefrologia (English Version). 2024;44:568-75